FR2361414A1 - Processus de determination d'immunite en utilisant de nouveaux composes immunochimiques - Google Patents

Processus de determination d'immunite en utilisant de nouveaux composes immunochimiques

Info

Publication number
FR2361414A1
FR2361414A1 FR7713206A FR7713206A FR2361414A1 FR 2361414 A1 FR2361414 A1 FR 2361414A1 FR 7713206 A FR7713206 A FR 7713206A FR 7713206 A FR7713206 A FR 7713206A FR 2361414 A1 FR2361414 A1 FR 2361414A1
Authority
FR
France
Prior art keywords
determination process
compounds
immunochemical
immunity determination
immunity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7713206A
Other languages
English (en)
French (fr)
Other versions
FR2361414B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beckman Coulter Inc
Original Assignee
Beckman Instruments Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/682,830 external-priority patent/US4081246A/en
Priority claimed from US05/682,808 external-priority patent/US4081245A/en
Priority claimed from US05/682,807 external-priority patent/US4081244A/en
Application filed by Beckman Instruments Inc filed Critical Beckman Instruments Inc
Publication of FR2361414A1 publication Critical patent/FR2361414A1/fr
Application granted granted Critical
Publication of FR2361414B1 publication Critical patent/FR2361414B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G01N33/541—Double or second antibody, i.e. precipitating antibody

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
FR7713206A 1976-05-03 1977-05-02 Processus de determination d'immunite en utilisant de nouveaux composes immunochimiques Granted FR2361414A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/682,830 US4081246A (en) 1976-05-03 1976-05-03 Solid phase column immunoassay procedure employing novel immunochemical composites
US05/682,808 US4081245A (en) 1976-05-03 1976-05-03 Immunoassay procedure employing novel immunochemical composites
US05/682,807 US4081244A (en) 1976-05-03 1976-05-03 Immunoassay procedure employing novel immunochemical composites

Publications (2)

Publication Number Publication Date
FR2361414A1 true FR2361414A1 (fr) 1978-03-10
FR2361414B1 FR2361414B1 (OSRAM) 1982-11-19

Family

ID=27418405

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7713206A Granted FR2361414A1 (fr) 1976-05-03 1977-05-02 Processus de determination d'immunite en utilisant de nouveaux composes immunochimiques

Country Status (10)

Country Link
JP (1) JPS52134020A (OSRAM)
AU (1) AU510210B2 (OSRAM)
CH (1) CH629894A5 (OSRAM)
DE (1) DE2719772A1 (OSRAM)
ES (1) ES458411A1 (OSRAM)
FR (1) FR2361414A1 (OSRAM)
GB (1) GB1588253A (OSRAM)
IT (1) IT1081386B (OSRAM)
NL (1) NL7704784A (OSRAM)
NZ (1) NZ183970A (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54147913A (en) * 1978-05-12 1979-11-19 Unitika Ltd Preparation of immunoadsorbent
FR2459479B1 (fr) * 1979-06-21 1983-07-08 Inst Nat Sante Rech Med Procede de separation d'une substance proteinique a partir d'une solution la contenant par filtration d'affinite et application dudit procede aux dosages enzymatiques
DE3019163C2 (de) 1980-05-20 1984-07-26 B.A.T. Cigaretten-Fabriken Gmbh, 2000 Hamburg Verwendung von Aminogruppen enthaltenden Cellulosefasern als Material für Tabakrauchfilter
US4778751A (en) * 1986-05-12 1988-10-18 Diagnostic Products Corporation Method for measuring antigens or antibodies in biological fluids using ligand labeled antigens or ligand labeled antibodies
DE4140142A1 (de) * 1991-12-05 1993-06-09 Boehringer Mannheim Gmbh, 6800 Mannheim, De Multivalentes dextranreagenz zum einsatz in praezipitationstests
DE4229378A1 (de) * 1992-09-03 1994-03-10 Daimler Benz Ag Verbindung für Rohrenden

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867366A (en) * 1972-11-06 1975-02-18 Synvar Associates A K A Syva C Opiate imidates and protein conjugates thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867366A (en) * 1972-11-06 1975-02-18 Synvar Associates A K A Syva C Opiate imidates and protein conjugates thereof

Also Published As

Publication number Publication date
AU2471977A (en) 1978-11-02
CH629894A5 (en) 1982-05-14
GB1588253A (en) 1981-04-23
NL7704784A (nl) 1977-11-07
ES458411A1 (es) 1978-12-01
AU510210B2 (en) 1980-06-12
IT1081386B (it) 1985-05-21
JPS52134020A (en) 1977-11-09
NZ183970A (en) 1979-06-08
DE2719772A1 (de) 1977-11-24
FR2361414B1 (OSRAM) 1982-11-19

Similar Documents

Publication Publication Date Title
EP0004940B1 (de) Verfahren zur radioimmunologischen Bestimmung von Prokollagen (Typ III) und Prokollagen-Peptid (Typ III), zur Herstellung von für das Verfahren geeignetem Prokollagen-Peptid (Typ III) und zur Herstellung von Anti-Prokollagen-Peptid (Typ III)-Serum
ES2091323T3 (es) Medios de contraste.
Izui et al. Selective suppression of retroviral gp70-anti-gp70 immune complex formation by prostaglandin E1 in murine systemic lupus erythematosus.
FR2409253A1 (fr) Procede de production d'esters carboxyliques
FR2445149A1 (fr) Composition pharmaceutique ayant une activite antitumorale
EP0069678A3 (fr) Dérivés de 3-fucosyl-N-acétyl lactosamine, leur préparation et leurs applications biologiques
CA2172663A1 (en) Improved reagents for a cannabinoid immunoassay
KR930701169A (ko) 면역억제제로서의 3-페닐-5,6-디하이드로벤즈[c]아크리딘-7-카복실산 및 관련 화합물
DE3850931T2 (de) Heterobifunktionelle Kupplungsmittel.
Bruijn et al. Anti-basement membrane glomerulopathy in experimental trypanosomiasis.
Critchley et al. Characterization of the cholera toxin receptor on Balb/c 3T3 cells as a ganglioside similar to, or identical with, ganglioside GM1. No evidence for galactoproteins with receptor activity
FR2457295A1 (fr) Composes intermediaires pour la preparation de cephalosporines
FR2361414A1 (fr) Processus de determination d'immunite en utilisant de nouveaux composes immunochimiques
Mardiney Jr et al. Ultrastructural localization of the third and fourth components of complement on complement-cell complexes
Cookson et al. Structural homology of cytochromes c
FR2394604A1 (fr) Composition detergente granulaire ou pulverulente de fluidite elevee
ATE120233T1 (de) Monoklonale antikörper, b-spezifisch für apolipoprotein, die von zwei hybridomen erzeugt werden.
Teague et al. Changes in monosaccharide content of mucous glycoproteins in ulcerative colitis
Okuda et al. Deposition of autologous gamma globulin in kidneys of rats with nephrotic renal disease of various etiologies
Schlesinger et al. A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high-risk individuals
DK0937092T3 (da) Faste bærematrixer indeholdende et oligosaccharid, som binder toksiner
Anderson et al. Polymer modification of antibody to eliminate immune complex and Fc binding
Bruyn et al. 1H NMR Study of Methyl O-Acetyl-α-and-β-D-Xylopyranosides Conformational Studies and Non Additivity of 1H-Shift Increments
DE59105603D1 (de) Monoklonale antikörper gegen den interleukin 2-rezeptor.
Weidner et al. Characterization of interactions involving anti-metatype antibodies and immune complexes

Legal Events

Date Code Title Description
ST Notification of lapse